COVID-19 Impact on Next-Generation Drug-Eluting Stent Market , Global Research Reports 2020-2021
- BMR3860362
- 91 Pages
- May 2020
- Medical Devices
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
This report provides a complete quantitative data and qualitative analysis on the global market for Next-Generation Drug-Eluting Stent. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Next-Generation Drug-Eluting Stent was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Next-Generation Drug-Eluting Stent is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Next-Generation Drug-Eluting Stent, including the following market information:
Global Next-Generation Drug-Eluting Stent Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Next-Generation Drug-Eluting Stent Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Next-Generation Drug-Eluting Stent Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Next-Generation Drug-Eluting Stent Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Abbott, Biosensors International, Medtronic, Sorin Group, SMT, Terumo, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Cobalt Chromium
Stainless Steel
Others
Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Next-Generation Drug-Eluting Stent Industry
1.7 COVID-19 Impact: Next-Generation Drug-Eluting Stent Market Trends
2 Global Next-Generation Drug-Eluting Stent Quarterly Market Size Analysis
2.1 Next-Generation Drug-Eluting Stent Business Impact Assessment - COVID-19
2.1.1 Global Next-Generation Drug-Eluting Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Next-Generation Drug-Eluting Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Next-Generation Drug-Eluting Stent Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Next-Generation Drug-Eluting Stent Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Next-Generation Drug-Eluting Stent Factory Price by Manufacturers
3.3 Location of Key Manufacturers Next-Generation Drug-Eluting Stent Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
3.5 Key Manufacturers Next-Generation Drug-Eluting Stent Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Next-Generation Drug-Eluting Stent Segments, By Type
4.1 Introduction
1.4.1 Cobalt Chromium
1.4.2 Stainless Steel
1.4.3 Others
4.2 By Type, Global Next-Generation Drug-Eluting Stent Market Size, 2019-2021
4.2.1 By Type, Global Next-Generation Drug-Eluting Stent Market Size by Type, 2020-2021
4.2.2 By Type, Global Next-Generation Drug-Eluting Stent Price, 2020-2021
5 Impact of Covid-19 on Next-Generation Drug-Eluting Stent Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgical Centers
5.2 By Application, Global Next-Generation Drug-Eluting Stent Market Size, 2019-2021
5.2.1 By Application, Global Next-Generation Drug-Eluting Stent Market Size by Application, 2019-2021
5.2.2 By Application, Global Next-Generation Drug-Eluting Stent Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.1.3 Abbott Next-Generation Drug-Eluting Stent Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 Biosensors International
7.2.1 Biosensors International Business Overview
7.2.2 Biosensors International Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.2.3 Biosensors International Next-Generation Drug-Eluting Stent Product Introduction
7.2.4 Biosensors International Response to COVID-19 and Related Developments
7.3 Medtronic
7.3.1 Medtronic Business Overview
7.3.2 Medtronic Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.3.3 Medtronic Next-Generation Drug-Eluting Stent Product Introduction
7.3.4 Medtronic Response to COVID-19 and Related Developments
7.4 Sorin Group
7.4.1 Sorin Group Business Overview
7.4.2 Sorin Group Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.4.3 Sorin Group Next-Generation Drug-Eluting Stent Product Introduction
7.4.4 Sorin Group Response to COVID-19 and Related Developments
7.5 SMT
7.5.1 SMT Business Overview
7.5.2 SMT Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.5.3 SMT Next-Generation Drug-Eluting Stent Product Introduction
7.5.4 SMT Response to COVID-19 and Related Developments
7.6 Terumo
7.6.1 Terumo Business Overview
7.6.2 Terumo Next-Generation Drug-Eluting Stent Quarterly Production and Revenue, 2020
7.6.3 Terumo Next-Generation Drug-Eluting Stent Product Introduction
7.6.4 Terumo Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Next-Generation Drug-Eluting Stent Supply Chain Analysis
8.1.1 Next-Generation Drug-Eluting Stent Supply Chain Analysis
8.1.2 Covid-19 Impact on Next-Generation Drug-Eluting Stent Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Next-Generation Drug-Eluting Stent Distribution Channels
8.2.2 Covid-19 Impact on Next-Generation Drug-Eluting Stent Distribution Channels
8.2.3 Next-Generation Drug-Eluting Stent Distributors
8.3 Next-Generation Drug-Eluting Stent Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Next-Generation Drug-Eluting Stent Assessment
Table 9. COVID-19 Impact: Next-Generation Drug-Eluting Stent Market Trends
Table 10. COVID-19 Impact Global Next-Generation Drug-Eluting Stent Market Size
Table 11. Global Next-Generation Drug-Eluting Stent Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Next-Generation Drug-Eluting Stent Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Next-Generation Drug-Eluting Stent Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Next-Generation Drug-Eluting Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Next-Generation Drug-Eluting Stent Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Next-Generation Drug-Eluting Stent Market Growth Drivers
Table 17. Global Next-Generation Drug-Eluting Stent Market Restraints
Table 18. Global Next-Generation Drug-Eluting Stent Market Opportunities
Table 19. Global Next-Generation Drug-Eluting Stent Market Challenges
Table 20. Key Manufacturers Next-Generation Drug-Eluting Stent Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Next-Generation Drug-Eluting Stent Market Size, 2019 (K Units) & (US$ Million)
Table 22. Next-Generation Drug-Eluting Stent Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Next-Generation Drug-Eluting Stent Manufacturing Plants
Table 24. Key Manufacturers Next-Generation Drug-Eluting Stent Market Served
Table 25. Date of Key Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
Table 26. Key Manufacturers Next-Generation Drug-Eluting Stent Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Next-Generation Drug-Eluting Stent Market Size by Type, 2020, (US$ Million)
Table 29. Global Next-Generation Drug-Eluting Stent Market Size by Type, 2020 (K Units)
Table 30. Global Next-Generation Drug-Eluting Stent Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Next-Generation Drug-Eluting Stent Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Next-Generation Drug-Eluting Stent Market Size by Application, 2020-2021 (K Units)
Table 33. Global Next-Generation Drug-Eluting Stent Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Next-Generation Drug-Eluting Stent Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Next-Generation Drug-Eluting Stent Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (K Units)
Table 38. US Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (K Units)
Table 43. Germany Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (K Units)
Table 50. China Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Next-Generation Drug-Eluting Stent Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Business Overview
Table 58. Abbott Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Next-Generation Drug-Eluting Stent Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. Biosensors International Business Overview
Table 62. Biosensors International Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Biosensors International Next-Generation Drug-Eluting Stent Product
Table 64. Biosensors International Response to COVID-19 and Related Developments
Table 65. Medtronic Business Overview
Table 66. Medtronic Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Medtronic Next-Generation Drug-Eluting Stent Product
Table 68. Medtronic Response to COVID-19 and Related Developments
Table 69. Sorin Group Business Overview
Table 70. Sorin Group Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Sorin Group Next-Generation Drug-Eluting Stent Product
Table 72. Sorin Group Response to COVID-19 and Related Developments
Table 73. SMT Business Overview
Table 74. SMT Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. SMT Next-Generation Drug-Eluting Stent Product
Table 76. SMT Response to COVID-19 and Related Developments
Table 77. Terumo Business Overview
Table 78. Terumo Next-Generation Drug-Eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Terumo Next-Generation Drug-Eluting Stent Product
Table 80. Terumo Response to COVID-19 and Related Developments
Table 81. Next-Generation Drug-Eluting Stent Distributors List
Table 82. Next-Generation Drug-Eluting Stent Customers List
Table 83. Covid-19 Impact on Next-Generation Drug-Eluting Stent Customers
List of Figures
Figure 1. Next-Generation Drug-Eluting Stent Product Picture
Figure 2. Next-Generation Drug-Eluting Stent Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Next-Generation Drug-Eluting Stent Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Next-Generation Drug-Eluting Stent Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Next-Generation Drug-Eluting Stent Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Next-Generation Drug-Eluting Stent Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Next-Generation Drug-Eluting Stent Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Next-Generation Drug-Eluting Stent Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Next-Generation Drug-Eluting Stent Market Size Market Share, 2019-2021
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
